His primary areas of study are Microbiology, Burkholderia cepacia complex, Burkholderia, Burkholderia contaminans and Genomovar. His Microbiology study combines topics in areas such as Bacteria, Molecular epidemiology, Cystic fibrosis and Virulence. His Burkholderia cepacia complex research is multidisciplinary, incorporating elements of Burkholderia cenocepacia, Sequence analysis and Multilocus sequence typing.
His work in Burkholderia cenocepacia addresses issues such as Pathogen, which are connected to fields such as Infection control, Drug resistance and Antibiotic resistance. His study in Genomovar is interdisciplinary in nature, drawing from both Burkholderia vietnamiensis and Burkholderia stabilis. His work in Burkholderia multivorans covers topics such as Burkholderia ambifaria which are related to areas like Immunology and Chronic infection.
Eshwar Mahenthiralingam mainly focuses on Microbiology, Burkholderia cepacia complex, Burkholderia, Genetics and Cystic fibrosis. His Microbiology research is multidisciplinary, relying on both Pseudomonas aeruginosa, Bacteria, Burkholderia multivorans, Burkholderia cenocepacia and Genomovar. In his study, RAPD is strongly linked to Typing, which falls under the umbrella field of Genomovar.
His work is dedicated to discovering how Burkholderia cepacia complex, Genotype are connected with Outbreak and other disciplines. The Burkholderia study combines topics in areas such as Identification, Achromobacter and Virulence. He interconnects Sputum, Pathogen, Immunology and Pathology in the investigation of issues within Cystic fibrosis.
His primary scientific interests are in Bacteria, Burkholderia, Microbiology, Genome and Genetics. The various areas that Eshwar Mahenthiralingam examines in his Bacteria study include Stringent response, Soil contamination and Gene. His Burkholderia study focuses mostly on Burkholderia cepacia complex and Burkholderia ambifaria.
His research integrates issues of Environmental chemistry and Bioremediation in his study of Burkholderia cepacia complex. His specific area of interest is Microbiology, where he studies Antibiotics. His Genomics, Strain and Multilocus sequence typing study in the realm of Genetics interacts with subjects such as Phylogenomics and Prophage.
Eshwar Mahenthiralingam focuses on Microbiology, Burkholderia gladioli, Pseudomonas aeruginosa, Genetics and Burkholderia. Eshwar Mahenthiralingam applies his multidisciplinary studies on Microbiology and Phenoxyethanol in his research. His Burkholderia gladioli research is multidisciplinary, incorporating perspectives in Biochemistry and Gene.
His research in Pseudomonas aeruginosa intersects with topics in Internal medicine, Cystic fibrosis, Molecular epidemiology, Operon and Pseudomonas. He is interested in Burkholderia cepacia complex, which is a field of Burkholderia. Eshwar Mahenthiralingam focuses mostly in the field of Plasmid, narrowing it down to topics relating to Genome and, in certain cases, Multilocus sequence typing.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The multifarious, multireplicon Burkholderia cepacia complex
Eshwar Mahenthiralingam;Teresa A. Urban;Joanna B. Goldberg.
Nature Reviews Microbiology (2005)
DNA-Based Diagnostic Approaches for Identification of Burkholderia cepacia Complex, Burkholderia vietnamiensis, Burkholderia multivorans,Burkholderia stabilis, and Burkholderia cepacia Genomovars I and III
Eshwar Mahenthiralingam;Jocelyn Bischof;Sean K. Byrne;Christopher Radomski.
Journal of Clinical Microbiology (2000)
Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.
Eshwar Mahenthiralingam;M. E. Campbell;D. P. Speert.
Infection and Immunity (1994)
Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology
Eshwar Mahenthiralingam;A. Baldwin;Christopher G. Dowson.
Journal of Applied Microbiology (2008)
Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.
Eshwar Mahenthiralingam;M. E. Campbell;J. Foster;J. S. Lam.
Journal of Clinical Microbiology (1996)
Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex
Eshwar Mahenthiralingam;Tom Coenye;Jacqueline W. Chung;David P. Speert.
Journal of Clinical Microbiology (2000)
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence
P. Drevinek;Eshwar Mahenthiralingam.
Clinical Microbiology and Infection (2010)
Burkholderia xenovorans LB400 harbors a multi-replicon, 9.73-Mbp genome shaped for versatility
Patrick S. G. Chain;Vincent J. Denef;Konstantinos T. Konstantinidis;Konstantinos T. Konstantinidis;Lisa M. Vergez;Lisa M. Vergez.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
Elke Vanlaere;Adam Baldwin;Dirk Gevers;Deborah Henry.
International Journal of Systematic and Evolutionary Microbiology (2009)
The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients
Matthew T. G. Holden;Helena M. B. Seth-Smith;Lisa C. Crossman;Mohammed Sebaihia.
Journal of Bacteriology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Ghent University
University of Warwick
University of Michigan–Ann Arbor
University of Warwick
Ghent University
University of Cambridge
University of British Columbia
Cardiff University
Imperial College London
University of Edinburgh
University of California, San Francisco
ETH Zurich
Heidelberg University
University of Tokyo
Tohoku University
Imperial College London
Lamont-Doherty Earth Observatory
Johannes Gutenberg University of Mainz
The University of Texas Health Science Center at San Antonio
Turku University Hospital
University of Rochester Medical Center
Arizona State University
University of Mississippi
Rutgers, The State University of New Jersey
University of Birmingham
University of Surrey